Dolce Aesthetics NY
Dolce Aesthetics NY

Dolce Aesthetics NY Information

Contact top employees from Dolce Aesthetics NY

Summary

Dolce Aesthetics NY is a private company. The company currently specializes in the Individual & Family Services area. Its headquarters is located at Brooklyn, New York, USA. The number of employees ranges from 25 to 100. The annual revenue of Dolce Aesthetics NY varies between 100K and 5.0M. To connect with Dolce Aesthetics NY employee register on SignalHire.

Industries

Individual & Family Services

Headquarters Location

Employees Size

1-10 employees

SIC Code

7900

DMA Code

New York Metropolitan Area

Estimated Annual Revenue

$100K - 5.0M

Operating Status

Independent Company

Contact Dolce Aesthetics NY

Organization Website

Social Links

twitterfacebook

Phone Number

718.745.3941

Competitors

Founded
Type
Employees
Revenue
Funding
1974Privately
Held
25 - 100 14.7M $10M
2005Public
Company
1.0K - 5.0K 1.9B $105.6M
2009Public
Company
1 - 25 < 1M $20M
1888Public
Company
100K - 9.9M 40.2B $6.9M
1876Public
Company
10K - 50K 26.7B $0
1935Public
Company
10K - 50K 2.6B $0
1858Public
Company
10K - 50K 44.4B $0
2014- 200-500 - $-
1896- 10000+ - $-

Employees Turnover 3 quarter 2025

Length of Employment
arrow
Employee tenure at Dolce Aesthetics NY shows a diverse range of experience levels:
17% for 1–2 years17% for 5–7 years17% for 8–10 years50% have over 11 years of service at Dolce Aesthetics NY
Contact top employees from Dolce Aesthetics NY
Kaitlin Premosch
Medical Aesthetician
View
Gerilynn Bucchio
Account Operations Manager
View

FAQ

Dolce Aesthetics NY operates in the Individual & Family Services industries. More details can be found on the official website: dolceaestheticsny.com.
The headquarters of Dolce Aesthetics NY are located in Glendale, United States.
You can contact Dolce Aesthetics NY by phone at 718.745.3941.
Dolce Aesthetics NY currently employs 1-10 people.
Dolce Aesthetics NY's revenue is approximately < 1M.
Well-known competitors of Dolce Aesthetics NY include HIGH TIMES, Ubiquiti Inc., Vicore Pharma AB and Abbott.
BACK TO TOP